Compare Canopy Growth Corp (CGC) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Uranium Energy Corp — how do they compare? Canopy Growth Corp trades at $0.98 (market cap $398.46M), while Uranium Energy Corp trades at $10.15 (market cap $5.14B). The key difference: Uranium Energy Corp is far larger — about 12.9× Canopy Growth Corp's market cap, and Uranium Energy Corp is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | UEC | |
|---|---|---|
Market Cap | $398.46M | $5.14B |
Sector | Health | Energy |
52-Week High | $1.92 | $20.14 |
52-Week Low | $0.86 | $6.98 |
Enterprise Value | $337.90M | $4.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Uranium Energy (UEC) trades at $10.07, down 4.37% today, reflecting ongoing operational challenges. The stock shows a bearish technical trend with key support at $10. Fundamentally, the company reported a net loss of $87.66 million in 2025 on $66.84 million revenue, with negative margins and a high P/S ratio of 242.83. Recent news highlights strategic positioning in U.S. uranium production but notes execution risks and cost pressures.
The outlook remains speculative; UEC's $794 million liquidity and debt-free balance sheet support growth initiatives, but persistent losses and volatile earnings create significant risk. Analyst consensus is 87.5% buy, targeting production ramp-ups, yet investors face uncertainty from licensing delays and uranium price fluctuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
